© 2025 Global Health Care AG
EasyMotionSkin Tec AG/Key word (s): Forecast
EasyMotionSkin Tec AG expects Group sales of CHF 27-32 million and negative EBITDA in the low single-digit million CHF range/ Significant growth also planned for 2024
13.11.2023/17:19 CET/CEST
Publication of inside information in accordance with Article 17 of Regulation (EU) No 596/2014, transmitted by EQS News — a service provided by EQS Group AG. The issuer/publisher is responsible for the content of the announcement.
EasyMotionSkin Tec AG expects Group sales of CHF 27-32 million and negative EBITDA in the low single-digit million CHF range/ Significant growth also planned for 2024
Vaduz, November 13, 2023 — EasyMotionSkin Tec AG (“EasyMotionSkin”, ISIN: LI114715831, m:access) publishes its forecast for fiscal year 2023. Following the course of the financial year so far and the acquisition of milongroup (see Corporate News dated 25.9.2023), the Board of Directors now expects Group sales in the current year in a range of CHF 27 — 32 million in 2022 had EasyMotionSKin generates sales of CHF 9.8 million. In the current financial year, EasyMotionSkin has tightened its corporate structures and created the basis for additional product innovations and an expanded sales concept. For the current year, the Group is expected to have a negative EBITDA in the low single-digit million CHF range, which already includes the one-time expenses for the takeover of milongroup. For 2024, EasyMotionSkin expects sales growth of at least the lower double-digit percentage range and a very significant improvement in earnings. In addition to the clearly defined growth strategy, the synergy potential between the previous companies of EasyMotionSkin Tec AG and milongroup, which will be exploited promptly, will also contribute to this. The capital increase, as part of which milongroup was incorporated into EasyMotionSkin Tec AG, has now been entered in the commercial register.
End of inside information
